LogicFlo AI, a startup optimizing regulatory and operational workflows for life sciences companies using artificial ...

FDA decision will enable Iksuda to expand its ongoing clinical trial in the US, Australia and Singapore Preliminary data from an ongoing dose-escalation study of IKS014 has shown meaningful clinical ...

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

Following positive opinion, Carthera is one of the first companies to benefit from brand-new status – intended to support early access pathways for innovative devices targeting rare diseasesParis, ...

The growing global burden of neuropsychiatric disorders is a critical driver for the treatment market. With over 9.1 million annual deaths attributed to neurological diseases and an additional 8 ...

Report Metric Details Base year considered 2023 Forecast period considered 2024-2029 Base year market size $108.

Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

AI-powered ChemPerturb-seq reveals sex-specific cocktail improving islet transplant survival, offering a new treatment for ...

Builds on clearances already received by FDA and EMAChina has the largest population of patients ... 5,6 Tumor size, number of tumors, and portal vein invasion are associated with an increased risk of ...

Ghana has marked its first official celebration of International MSME Day with a bold commitment to reposition the Micro, ...

Pierre-Alexandre Teulié, founder and CEO of Oddifact, has been recognised by Business Worldwide Magazine as the "Most Innovative CEO in ...